ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ranibizumab Drugs and Biosimilars Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-3H18125
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Ranibizumab Drugs and Biosimilars Market Research Report 2024
BUY CHAPTERS

Global Ranibizumab Drugs and Biosimilars Market Research Report 2024

Code: QYRE-Auto-3H18125
Report
August 2024
Pages:71
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Samsung Bioepis
Coherus BioSciences

Ranibizumab Drugs and Biosimilars Market

Ranibizumab is a monoclonal antibody fragment that targets vascular endothelial growth factor(VEGF),used primarily in the treatment of eye diseases such as wet age-related macular degeneration(AMD)and diabetic eye disease.Biosimilars of ranibizumab are biologic products that are highly similar to the original reference drug(ranibizumab)in terms of structure,efficacy,safety,and quality.These biosimilars aim to provide more affordable treatment options while maintaining therapeutic equivalence to the original biologic drug.
The global Ranibizumab Drugs and Biosimilars market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Ranibizumab Drugs and Biosimilars is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ranibizumab Drugs and Biosimilars is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ranibizumab Drugs and Biosimilars include Roche, Samsung Bioepis, Coherus Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ranibizumab Drugs and Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ranibizumab Drugs and Biosimilars.
The Ranibizumab Drugs and Biosimilars market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Ranibizumab Drugs and Biosimilars market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ranibizumab Drugs and Biosimilars manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ranibizumab Drugs and Biosimilars Market Report

Report Metric Details
Report Name Ranibizumab Drugs and Biosimilars Market
Segment by Type
  • 0.5mg per Vial
  • 2mg per Vial
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Samsung Bioepis, Coherus Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ranibizumab Drugs and Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ranibizumab Drugs and Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Ranibizumab Drugs and Biosimilars Market report?

Ans: The main players in the Ranibizumab Drugs and Biosimilars Market are Roche, Samsung Bioepis, Coherus Biosciences

What are the Application segmentation covered in the Ranibizumab Drugs and Biosimilars Market report?

Ans: The Applications covered in the Ranibizumab Drugs and Biosimilars Market report are Degenerative Eye Diseases, Cancer, Other

What are the Type segmentation covered in the Ranibizumab Drugs and Biosimilars Market report?

Ans: The Types covered in the Ranibizumab Drugs and Biosimilars Market report are 0.5mg per Vial, 2mg per Vial

Recommended Reports

Biosimilars & Biologics

Eye Drug Markets

VEGF Targeted Drugs

1 Ranibizumab Drugs and Biosimilars Market Overview
1.1 Product Definition
1.2 Ranibizumab Drugs and Biosimilars by Type
1.2.1 Global Ranibizumab Drugs and Biosimilars Market Value Comparison by Type (2024-2030)
1.2.2 0.5mg per Vial
1.2.3 2mg per Vial
1.3 Ranibizumab Drugs and Biosimilars by Application
1.3.1 Global Ranibizumab Drugs and Biosimilars Market Value by Application (2024-2030)
1.3.2 Degenerative Eye Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Global Ranibizumab Drugs and Biosimilars Market Size Estimates and Forecasts
1.4.1 Global Ranibizumab Drugs and Biosimilars Revenue 2019-2030
1.4.2 Global Ranibizumab Drugs and Biosimilars Sales 2019-2030
1.4.3 Global Ranibizumab Drugs and Biosimilars Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ranibizumab Drugs and Biosimilars Market Competition by Manufacturers
2.1 Global Ranibizumab Drugs and Biosimilars Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ranibizumab Drugs and Biosimilars Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ranibizumab Drugs and Biosimilars Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Ranibizumab Drugs and Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ranibizumab Drugs and Biosimilars, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ranibizumab Drugs and Biosimilars, Product Type & Application
2.7 Global Key Manufacturers of Ranibizumab Drugs and Biosimilars, Date of Enter into This Industry
2.8 Global Ranibizumab Drugs and Biosimilars Market Competitive Situation and Trends
2.8.1 Global Ranibizumab Drugs and Biosimilars Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ranibizumab Drugs and Biosimilars Players Market Share by Revenue
2.8.3 Global Ranibizumab Drugs and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ranibizumab Drugs and Biosimilars Market Scenario by Region
3.1 Global Ranibizumab Drugs and Biosimilars Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ranibizumab Drugs and Biosimilars Sales by Region: 2019-2030
3.2.1 Global Ranibizumab Drugs and Biosimilars Sales by Region: 2019-2024
3.2.2 Global Ranibizumab Drugs and Biosimilars Sales by Region: 2025-2030
3.3 Global Ranibizumab Drugs and Biosimilars Revenue by Region: 2019-2030
3.3.1 Global Ranibizumab Drugs and Biosimilars Revenue by Region: 2019-2024
3.3.2 Global Ranibizumab Drugs and Biosimilars Revenue by Region: 2025-2030
3.4 North America Ranibizumab Drugs and Biosimilars Market Facts & Figures by Country
3.4.1 North America Ranibizumab Drugs and Biosimilars Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ranibizumab Drugs and Biosimilars Sales by Country (2019-2030)
3.4.3 North America Ranibizumab Drugs and Biosimilars Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ranibizumab Drugs and Biosimilars Market Facts & Figures by Country
3.5.1 Europe Ranibizumab Drugs and Biosimilars Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ranibizumab Drugs and Biosimilars Sales by Country (2019-2030)
3.5.3 Europe Ranibizumab Drugs and Biosimilars Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ranibizumab Drugs and Biosimilars Market Facts & Figures by Region
3.6.1 Asia Pacific Ranibizumab Drugs and Biosimilars Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ranibizumab Drugs and Biosimilars Sales by Region (2019-2030)
3.6.3 Asia Pacific Ranibizumab Drugs and Biosimilars Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ranibizumab Drugs and Biosimilars Market Facts & Figures by Country
3.7.1 Latin America Ranibizumab Drugs and Biosimilars Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ranibizumab Drugs and Biosimilars Sales by Country (2019-2030)
3.7.3 Latin America Ranibizumab Drugs and Biosimilars Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Ranibizumab Drugs and Biosimilars Market Facts & Figures by Country
3.8.1 Middle East and Africa Ranibizumab Drugs and Biosimilars Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ranibizumab Drugs and Biosimilars Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ranibizumab Drugs and Biosimilars Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ranibizumab Drugs and Biosimilars Sales by Type (2019-2030)
4.1.1 Global Ranibizumab Drugs and Biosimilars Sales by Type (2019-2024)
4.1.2 Global Ranibizumab Drugs and Biosimilars Sales by Type (2025-2030)
4.1.3 Global Ranibizumab Drugs and Biosimilars Sales Market Share by Type (2019-2030)
4.2 Global Ranibizumab Drugs and Biosimilars Revenue by Type (2019-2030)
4.2.1 Global Ranibizumab Drugs and Biosimilars Revenue by Type (2019-2024)
4.2.2 Global Ranibizumab Drugs and Biosimilars Revenue by Type (2025-2030)
4.2.3 Global Ranibizumab Drugs and Biosimilars Revenue Market Share by Type (2019-2030)
4.3 Global Ranibizumab Drugs and Biosimilars Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ranibizumab Drugs and Biosimilars Sales by Application (2019-2030)
5.1.1 Global Ranibizumab Drugs and Biosimilars Sales by Application (2019-2024)
5.1.2 Global Ranibizumab Drugs and Biosimilars Sales by Application (2025-2030)
5.1.3 Global Ranibizumab Drugs and Biosimilars Sales Market Share by Application (2019-2030)
5.2 Global Ranibizumab Drugs and Biosimilars Revenue by Application (2019-2030)
5.2.1 Global Ranibizumab Drugs and Biosimilars Revenue by Application (2019-2024)
5.2.2 Global Ranibizumab Drugs and Biosimilars Revenue by Application (2025-2030)
5.2.3 Global Ranibizumab Drugs and Biosimilars Revenue Market Share by Application (2019-2030)
5.3 Global Ranibizumab Drugs and Biosimilars Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Ranibizumab Drugs and Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Ranibizumab Drugs and Biosimilars Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Samsung Bioepis
6.2.1 Samsung Bioepis Company Information
6.2.2 Samsung Bioepis Description and Business Overview
6.2.3 Samsung Bioepis Ranibizumab Drugs and Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Samsung Bioepis Ranibizumab Drugs and Biosimilars Product Portfolio
6.2.5 Samsung Bioepis Recent Developments/Updates
6.3 Coherus Biosciences
6.3.1 Coherus Biosciences Company Information
6.3.2 Coherus Biosciences Description and Business Overview
6.3.3 Coherus Biosciences Ranibizumab Drugs and Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Coherus Biosciences Ranibizumab Drugs and Biosimilars Product Portfolio
6.3.5 Coherus Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ranibizumab Drugs and Biosimilars Industry Chain Analysis
7.2 Ranibizumab Drugs and Biosimilars Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ranibizumab Drugs and Biosimilars Production Mode & Process
7.4 Ranibizumab Drugs and Biosimilars Sales and Marketing
7.4.1 Ranibizumab Drugs and Biosimilars Sales Channels
7.4.2 Ranibizumab Drugs and Biosimilars Distributors
7.5 Ranibizumab Drugs and Biosimilars Customers
8 Ranibizumab Drugs and Biosimilars Market Dynamics
8.1 Ranibizumab Drugs and Biosimilars Industry Trends
8.2 Ranibizumab Drugs and Biosimilars Market Drivers
8.3 Ranibizumab Drugs and Biosimilars Market Challenges
8.4 Ranibizumab Drugs and Biosimilars Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Samsung Bioepis
Coherus BioSciences
List of Tables
 Table 1. Global Ranibizumab Drugs and Biosimilars Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Ranibizumab Drugs and Biosimilars Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Ranibizumab Drugs and Biosimilars Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Ranibizumab Drugs and Biosimilars Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Ranibizumab Drugs and Biosimilars Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Ranibizumab Drugs and Biosimilars Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Ranibizumab Drugs and Biosimilars Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Ranibizumab Drugs and Biosimilars Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Ranibizumab Drugs and Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ranibizumab Drugs and Biosimilars, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ranibizumab Drugs and Biosimilars, Product Type & Application
 Table 12. Global Key Manufacturers of Ranibizumab Drugs and Biosimilars, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ranibizumab Drugs and Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ranibizumab Drugs and Biosimilars as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ranibizumab Drugs and Biosimilars Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Ranibizumab Drugs and Biosimilars Sales by Region (2019-2024) & (K Units)
 Table 18. Global Ranibizumab Drugs and Biosimilars Sales Market Share by Region (2019-2024)
 Table 19. Global Ranibizumab Drugs and Biosimilars Sales by Region (2025-2030) & (K Units)
 Table 20. Global Ranibizumab Drugs and Biosimilars Sales Market Share by Region (2025-2030)
 Table 21. Global Ranibizumab Drugs and Biosimilars Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Ranibizumab Drugs and Biosimilars Revenue Market Share by Region (2019-2024)
 Table 23. Global Ranibizumab Drugs and Biosimilars Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Ranibizumab Drugs and Biosimilars Revenue Market Share by Region (2025-2030)
 Table 25. North America Ranibizumab Drugs and Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Ranibizumab Drugs and Biosimilars Sales by Country (2019-2024) & (K Units)
 Table 27. North America Ranibizumab Drugs and Biosimilars Sales by Country (2025-2030) & (K Units)
 Table 28. North America Ranibizumab Drugs and Biosimilars Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Ranibizumab Drugs and Biosimilars Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Ranibizumab Drugs and Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Ranibizumab Drugs and Biosimilars Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Ranibizumab Drugs and Biosimilars Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Ranibizumab Drugs and Biosimilars Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Ranibizumab Drugs and Biosimilars Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Ranibizumab Drugs and Biosimilars Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Ranibizumab Drugs and Biosimilars Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Ranibizumab Drugs and Biosimilars Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Ranibizumab Drugs and Biosimilars Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Ranibizumab Drugs and Biosimilars Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Ranibizumab Drugs and Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Ranibizumab Drugs and Biosimilars Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Ranibizumab Drugs and Biosimilars Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Ranibizumab Drugs and Biosimilars Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Ranibizumab Drugs and Biosimilars Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Ranibizumab Drugs and Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Ranibizumab Drugs and Biosimilars Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Ranibizumab Drugs and Biosimilars Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Ranibizumab Drugs and Biosimilars Sales (K Units) by Type (2019-2024)
 Table 51. Global Ranibizumab Drugs and Biosimilars Sales (K Units) by Type (2025-2030)
 Table 52. Global Ranibizumab Drugs and Biosimilars Sales Market Share by Type (2019-2024)
 Table 53. Global Ranibizumab Drugs and Biosimilars Sales Market Share by Type (2025-2030)
 Table 54. Global Ranibizumab Drugs and Biosimilars Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Ranibizumab Drugs and Biosimilars Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Ranibizumab Drugs and Biosimilars Revenue Market Share by Type (2019-2024)
 Table 57. Global Ranibizumab Drugs and Biosimilars Revenue Market Share by Type (2025-2030)
 Table 58. Global Ranibizumab Drugs and Biosimilars Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Ranibizumab Drugs and Biosimilars Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Ranibizumab Drugs and Biosimilars Sales (K Units) by Application (2019-2024)
 Table 61. Global Ranibizumab Drugs and Biosimilars Sales (K Units) by Application (2025-2030)
 Table 62. Global Ranibizumab Drugs and Biosimilars Sales Market Share by Application (2019-2024)
 Table 63. Global Ranibizumab Drugs and Biosimilars Sales Market Share by Application (2025-2030)
 Table 64. Global Ranibizumab Drugs and Biosimilars Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Ranibizumab Drugs and Biosimilars Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Ranibizumab Drugs and Biosimilars Revenue Market Share by Application (2019-2024)
 Table 67. Global Ranibizumab Drugs and Biosimilars Revenue Market Share by Application (2025-2030)
 Table 68. Global Ranibizumab Drugs and Biosimilars Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Ranibizumab Drugs and Biosimilars Price (US$/Unit) by Application (2025-2030)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Ranibizumab Drugs and Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Roche Ranibizumab Drugs and Biosimilars Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Samsung Bioepis Company Information
 Table 76. Samsung Bioepis Description and Business Overview
 Table 77. Samsung Bioepis Ranibizumab Drugs and Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Samsung Bioepis Ranibizumab Drugs and Biosimilars Product
 Table 79. Samsung Bioepis Recent Developments/Updates
 Table 80. Coherus Biosciences Company Information
 Table 81. Coherus Biosciences Description and Business Overview
 Table 82. Coherus Biosciences Ranibizumab Drugs and Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Coherus Biosciences Ranibizumab Drugs and Biosimilars Product
 Table 84. Coherus Biosciences Recent Developments/Updates
 Table 85. Key Raw Materials Lists
 Table 86. Raw Materials Key Suppliers Lists
 Table 87. Ranibizumab Drugs and Biosimilars Distributors List
 Table 88. Ranibizumab Drugs and Biosimilars Customers List
 Table 89. Ranibizumab Drugs and Biosimilars Market Trends
 Table 90. Ranibizumab Drugs and Biosimilars Market Drivers
 Table 91. Ranibizumab Drugs and Biosimilars Market Challenges
 Table 92. Ranibizumab Drugs and Biosimilars Market Restraints
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ranibizumab Drugs and Biosimilars
 Figure 2. Global Ranibizumab Drugs and Biosimilars Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Ranibizumab Drugs and Biosimilars Market Share by Type: 2023 & 2030
 Figure 4. 0.5mg per Vial Product Picture
 Figure 5. 2mg per Vial Product Picture
 Figure 6. Global Ranibizumab Drugs and Biosimilars Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Ranibizumab Drugs and Biosimilars Market Share by Application: 2023 & 2030
 Figure 8. Degenerative Eye Diseases
 Figure 9. Cancer
 Figure 10. Other
 Figure 11. Global Ranibizumab Drugs and Biosimilars Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Ranibizumab Drugs and Biosimilars Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Ranibizumab Drugs and Biosimilars Sales (2019-2030) & (K Units)
 Figure 14. Global Ranibizumab Drugs and Biosimilars Average Price (US$/Unit) & (2019-2030)
 Figure 15. Ranibizumab Drugs and Biosimilars Report Years Considered
 Figure 16. Ranibizumab Drugs and Biosimilars Sales Share by Manufacturers in 2023
 Figure 17. Global Ranibizumab Drugs and Biosimilars Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Ranibizumab Drugs and Biosimilars Players: Market Share by Revenue in Ranibizumab Drugs and Biosimilars in 2023
 Figure 19. Ranibizumab Drugs and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Ranibizumab Drugs and Biosimilars Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Ranibizumab Drugs and Biosimilars Sales Market Share by Country (2019-2030)
 Figure 22. North America Ranibizumab Drugs and Biosimilars Revenue Market Share by Country (2019-2030)
 Figure 23. United States Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Ranibizumab Drugs and Biosimilars Sales Market Share by Country (2019-2030)
 Figure 26. Europe Ranibizumab Drugs and Biosimilars Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Ranibizumab Drugs and Biosimilars Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Ranibizumab Drugs and Biosimilars Revenue Market Share by Region (2019-2030)
 Figure 34. China Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Ranibizumab Drugs and Biosimilars Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Ranibizumab Drugs and Biosimilars Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Ranibizumab Drugs and Biosimilars Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Ranibizumab Drugs and Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Ranibizumab Drugs and Biosimilars by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Ranibizumab Drugs and Biosimilars by Type (2019-2030)
 Figure 53. Global Ranibizumab Drugs and Biosimilars Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Ranibizumab Drugs and Biosimilars by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Ranibizumab Drugs and Biosimilars by Application (2019-2030)
 Figure 56. Global Ranibizumab Drugs and Biosimilars Price (US$/Unit) by Application (2019-2030)
 Figure 57. Ranibizumab Drugs and Biosimilars Value Chain
 Figure 58. Ranibizumab Drugs and Biosimilars Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Ranibizumab Injection Market Research Report 2024
Lucentis Ranibizumab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Raibizumab Biosimilars Market Research Report 2025
Global Broluzumab Biosimilars Market Research Report 2025
Global Monoclonal Antibody Anti VEGF Ophthalmic Drugs Market Research Report 2024
Global Biosimilar Bevacizuma Market Research Report 2024
Global Ranibizumab Market Research Report 2025
Global Single target Anti VEGF Drugs Market Research Report 2024
Global Rituximab Biosimilars Market Research Report 2025
Global Avastin Bevacizumab Biosimilars Market Research Report 2024
Global Anti VEGT Drugs Market Research Report 2024
Global Anti VEGF Ophthalmic Drugs Market Research Report 2024
Global Tocilizumab Biosimilars Market Research Report 2024
Bevacizumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Avastin Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global VEGF A Inhibitor Market Research Report 2024
Global Anti VEGF Intravitreal Drugs Market Research Report 2024
Global Monoclonal Antibody VEGF Inhibitors Market Research Report 2024
Global Anti VEGF Drugs for the Treatment of Wet AMD Market Research Report 2024
Global Biosimilar Antibodies Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions